FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073485652> ?p ?o ?g. }

• W2073485652 endingPage "512" @default.
• W2073485652 startingPage "505" @default.
• W2073485652 abstract "Visfatin, a newly discovered adipocytokine, is thought to play a role in the pathogenesis of metabolic-syndrome-related cancers. The aim of this study was to assess the clinical significance of serum levels and tissue expression of visfatin in relation to endometrial cancer (EC).A total of 234 EC patients were included in this study. Serum visfatin, metabolic and anthropometric parameters were measured in EC patients and controls. Serum visfatin levels were detected using ELISA. Tissue expression of visfatin was analyzed using immunohistochemistry in tissue microarrays. The correlation between clinicopathological variables and visfatin in EC tissues and the prognostic value of visfatin for overall survival was evaluated.Serum levels of visfatin were significantly higher in EC patients than in controls (P<0.05). In univariate and multivariate logistic regression models, a positive association between EC and serum visfatin, BMI, waist-to-hip ratio, diabetes, and hypertension was evident (P<0.05). Visfatin expression was significantly higher in EC tissue than in normal endometrial tissue (P=0.001). Moreover, serum visfatin levels were significantly positively correlated with tissue expression of visfatin in EC patients (P<0.05). High visfatin expression in EC tissues was significantly associated with advanced FIGO stage (P=0.016) and myometrial invasion ≥1/2 (P=0.023). The overall survival rate of EC patients was significantly higher in the group with negative visfatin expression than with positive visfatin expression (P=0.035).Visfatin is a potential serum biomarker and prognostic factor for EC that may indicate high risk for EC and EC progression. It may also be a novel potential therapeutic target for EC." @default.
• W2073485652 created "2016-06-24" @default.
• W2073485652 creator A5006817710 @default.
• W2073485652 creator A5020454755 @default.
• W2073485652 creator A5023810650 @default.
• W2073485652 creator A5047366974 @default.
• W2073485652 creator A5054682803 @default.
• W2073485652 creator A5061672339 @default.
• W2073485652 creator A5071985917 @default.
• W2073485652 creator A5073852874 @default.
• W2073485652 creator A5086108075 @default.
• W2073485652 creator A5091562719 @default.
• W2073485652 date "2013-06-01" @default.
• W2073485652 modified "2023-09-29" @default.
• W2073485652 title "Visfatin, a potential biomarker and prognostic factor for endometrial cancer" @default.
• W2073485652 cites W1971799300 @default.
• W2073485652 cites W1977369158 @default.
• W2073485652 cites W1980799482 @default.
• W2073485652 cites W1994099917 @default.
• W2073485652 cites W1996926257 @default.
• W2073485652 cites W2004224039 @default.
• W2073485652 cites W2006345894 @default.
• W2073485652 cites W2009190388 @default.
• W2073485652 cites W2011125600 @default.
• W2073485652 cites W2014748943 @default.
• W2073485652 cites W2016527093 @default.
• W2073485652 cites W2027680551 @default.
• W2073485652 cites W2076738420 @default.
• W2073485652 cites W2086672744 @default.
• W2073485652 cites W2092950801 @default.
• W2073485652 cites W2104532843 @default.
• W2073485652 cites W2115831525 @default.
• W2073485652 cites W2131253478 @default.
• W2073485652 cites W2133014069 @default.
• W2073485652 cites W2135110328 @default.
• W2073485652 cites W2139336758 @default.
• W2073485652 cites W2158145015 @default.
• W2073485652 cites W2165948908 @default.
• W2073485652 cites W2171904353 @default.
• W2073485652 cites W2317815883 @default.
• W2073485652 cites W2323643327 @default.
• W2073485652 doi "https://doi.org/10.1016/j.ygyno.2013.02.022" @default.
• W2073485652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23438672" @default.
• W2073485652 hasPublicationYear "2013" @default.
• W2073485652 type Work @default.
• W2073485652 sameAs 2073485652 @default.
• W2073485652 citedByCount "71" @default.
• W2073485652 countsByYear W20734856522013 @default.
• W2073485652 countsByYear W20734856522014 @default.
• W2073485652 countsByYear W20734856522015 @default.
• W2073485652 countsByYear W20734856522016 @default.
• W2073485652 countsByYear W20734856522017 @default.
• W2073485652 countsByYear W20734856522018 @default.
• W2073485652 countsByYear W20734856522019 @default.
• W2073485652 countsByYear W20734856522020 @default.
• W2073485652 countsByYear W20734856522021 @default.
• W2073485652 countsByYear W20734856522022 @default.
• W2073485652 countsByYear W20734856522023 @default.
• W2073485652 crossrefType "journal-article" @default.
• W2073485652 hasAuthorship W2073485652A5006817710 @default.
• W2073485652 hasAuthorship W2073485652A5020454755 @default.
• W2073485652 hasAuthorship W2073485652A5023810650 @default.
• W2073485652 hasAuthorship W2073485652A5047366974 @default.
• W2073485652 hasAuthorship W2073485652A5054682803 @default.
• W2073485652 hasAuthorship W2073485652A5061672339 @default.
• W2073485652 hasAuthorship W2073485652A5071985917 @default.
• W2073485652 hasAuthorship W2073485652A5073852874 @default.
• W2073485652 hasAuthorship W2073485652A5086108075 @default.
• W2073485652 hasAuthorship W2073485652A5091562719 @default.
• W2073485652 hasConcept C121608353 @default.
• W2073485652 hasConcept C126322002 @default.
• W2073485652 hasConcept C134018914 @default.
• W2073485652 hasConcept C171089720 @default.
• W2073485652 hasConcept C193270364 @default.
• W2073485652 hasConcept C194832188 @default.
• W2073485652 hasConcept C204232928 @default.
• W2073485652 hasConcept C2777088508 @default.
• W2073485652 hasConcept C2777391703 @default.
• W2073485652 hasConcept C2780942790 @default.
• W2073485652 hasConcept C2781197716 @default.
• W2073485652 hasConcept C511355011 @default.
• W2073485652 hasConcept C55493867 @default.
• W2073485652 hasConcept C71924100 @default.
• W2073485652 hasConcept C86803240 @default.
• W2073485652 hasConceptScore W2073485652C121608353 @default.
• W2073485652 hasConceptScore W2073485652C126322002 @default.
• W2073485652 hasConceptScore W2073485652C134018914 @default.
• W2073485652 hasConceptScore W2073485652C171089720 @default.
• W2073485652 hasConceptScore W2073485652C193270364 @default.
• W2073485652 hasConceptScore W2073485652C194832188 @default.
• W2073485652 hasConceptScore W2073485652C204232928 @default.
• W2073485652 hasConceptScore W2073485652C2777088508 @default.
• W2073485652 hasConceptScore W2073485652C2777391703 @default.
• W2073485652 hasConceptScore W2073485652C2780942790 @default.
• W2073485652 hasConceptScore W2073485652C2781197716 @default.
• W2073485652 hasConceptScore W2073485652C511355011 @default.
• W2073485652 hasConceptScore W2073485652C55493867 @default.
• W2073485652 hasConceptScore W2073485652C71924100 @default.

• next